New Concepts in ACS: Beyond 2000 (XXIII)

Monday, October 23
7:00-8:45 AM

Vancouver, BC

New Concepts in Heart Failure and Atrial Fibrillation: Beyond 2000 (XXIII)

Monday, October 23
8:45-10:30 AM

Vancouver, BC

Chair: Paul W. Armstrong

Co-Chair New Concepts in ACS: Beyond 2000 (XXIII):
Shaun Goodman

Co-Chair New Concepts in Heart Failure and Atrial Fibrillation: Beyond 2000 (XXIII):
Justin Ezekowitz

2017 Sponsors
of Beyond 2000

This accredited symposium was co-developed with the Canadian Cardiovascular Society, Mazankowski Alberta Heart Institute/University of Alberta, Canadian VIGOUR Centre, AstraZeneca Canada Inc., Bayer Inc., Merck Canada Inc. and Novartis Pharmaceuticals Canada Inc. and was planned to achieve scientific integrity, objectivity and balance.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™.

Live educational activities, occurring in Canada, recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC credits.


I am delighted to welcome you to the Beyond 2000 website. On behalf of my Co-Chairs, the Organizing Committee, and our faculty, I hope you found the 2017 symposium to be a valuable educational experience.

If you have not already done so, please complete the simple registration process to access the 2017 Resources page where you will find a variety of resources:

  • The presentation slides, generously provided by our faculty;
  • A series of discussions with our faculty that offer deeper insights into the highlights of their presentations;
  • Videos of the full presentations from the 2017 symposium;
  • Faculty responses to the questions submitted by members of the audience.

Resource materials from prior years also continue to be available in the site Archives.

I thank you for your continued interest in this symposium.


Paul Armstrong, MD
Program Chair

From 2017: Continuing the Conversation

Paul Armstrong speaks with Gregory Schwartz about New Options for Secondary Prevention with Lipid Modifying Therapy

Paul Armstrong speaks with Scott Solomon about New Therapies in Classifying and Managing Heart Failure

Like to see more?

Become a member to gain access to other resources from the 2017 symposium.

Already a Member?

You may access resources from 2017 and prior years through this website.